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Migraine is a chronic disease characterized by unilateral, pulsating, and often mod-
erate-to-severe recurrent episodes of headache with nausea and vomiting. It affects 
approximately 15% of the general population, yet the underlying pathophysiological 
mechanisms are not fully understood. Optical coherence tomography (OCT) is a safe and 
reproducible diagnostic technique that utilizes infrared wavelengths and has a sensitivity 
of 8–10 μm. It can be used to measure thinning of the retinal nerve fiber layer (RNFL) in 
some neurological disorders. Although ophthalmologists are often the first specialists 
to examine patients with migraine, few studies have addressed the involvement of the 
optic nerve and retino-choroidal structures in this group. We reviewed the literature on 
the etiological and pathological mechanisms of migraine and the relationship between 
recurrent constriction of cerebral and retrobulbar vessels and ischemic damage to the 
optic nerve, retina, and choroid. We also assessed the role of OCT for measuring peri-
papillary RNFL thickness and macular and choroidal changes in migraine patients. There 
is considerable evidence of cerebral and retrobulbar vascular involvement in the etiology 
of migraine. Transitory and recurrent constriction of the retinal and ciliary arteries may 
cause ischemic damage to the optic nerve, retina, and choroid in patients with migraine. 
OCT to assess the thickness of the peripapillary RNFL, macula, and choroid might 
increase our understanding of the pathophysiology of migraine and facilitate diagnosis 
of retino-choroidal compromise and follow-up of therapy in migraine patients. Future 
studies should determine the usefulness of OCT findings as a biomarker of migraine.
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inTRODUCTiOn
Migraine is a chronic disease characterized by unilateral, pulsating, and often moderate-to-severe 
repetitive episodes of headache and vegetative symptoms such as nausea, vomiting, and extreme 
sensitivity to light and sound (1). This condition affects approximately 15% of the general popula-
tion and is the most prevalent neurological disorder and the third most frequent global disorder 
in both genders (2). It mainly affects women aged 20–45 years (3, 4), and symptoms typically last 
4–72 h (5–7).
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Episodic migraine is defined as 0–14 headache days per 
month, whereas chronic migraine (CM) is defined as 15 or more 
headache days per month. Episodic migraine is classified into two 
major groups: migraine with aura (MwA, or classic migraine) 
and migraine without aura (MwoA, or common migraine) (8). 
Aura, which manifests as transient ocular and neurological dis-
turbances, including flashes of light, blind spots, periorbital pain, 
and photophobia, affects about 25% of patients, usually immedi-
ately before but sometimes following the headache (9, 10).
Clinical data support ocular involvement in migraine. Thus, 
visual field compromise resembling that described in glaucoma 
has been reported (11). Perimetric damage progressed more 
quickly in patients with normal-tension glaucoma (NTG) and 
headache than that in individuals with NTG and no migraine 
(12). Several authors have explored visual acuity and visual field 
testing in migraineurs, although they did not observe any dif-
ferences between migraineurs and controls (13, 14). Koban et al. 
(15) studied intraocular pressure (IOP) and biometric parameters 
and found no relevant differences between migraineurs during 
the attack and the healthy controls.
Optical Coherence Tomography (OCT),  
a Promising Technology in neurology
Decreased thickness of the retinal nerve fiber layer (RNFL) has 
been reported in several neurological disorders, such as multiple 
sclerosis, Alzheimer disease, and Parkinson disease (16–18). 
Ganglion cell layer (GCL) thickness could become a more appro-
priate morphological biomarker of axonal damage than RNFL in 
specific optic neuropathies (19, 20). OCT is a reliable, reproduc-
ible, objective, non-invasive, transpupillary diagnostic technique 
that enables quantitative in vivo high-resolution measurement of 
peripapillary RNFL, GCL, and choroid layer thickness (21–23). 
It generates a retinal cross-sectional map accurate to 5 µm. RNFL 
thickness is currently measured using OCT to assess glaucoma 
and maculopathies (24, 25). Decreased RNFL thickness has also 
been demonstrated by OCT in certain neurological disorders 
(26–30). In the last few years, several authors have used OCT 
to study whether the retina and choroid are involved in patients 
with migraine through the analysis of RNFL and macular and 
choroidal changes (Table 1).
vascular involvement in Migraine
Previous studies suggested that brain hypoperfusion is common 
in MwA (31, 32), probably because of hypercoagulability and 
altered endothelial and vascular smooth muscle (33). Although 
the underlying pathophysiological mechanisms of migraine are 
not fully understood and many hypotheses have been proposed 
(31, 34–37), there is increasing evidence that the neurovascular 
system is involved (10, 31–40). Migraine attacks affect the 
trigeminal vascular system (TGVS), including the network of 
intra- and extracranial meningeal blood vessels and ocular struc-
tures (41, 42), and regulate vascular tone and the transmission of 
pain signals (43). Following activation of the TGVS, vasoactive 
neurotransmitters are released from peripheral terminations of 
the trigeminal nerve, causing vascular and inflammatory changes 
that result in pain (44). Migraine typically occurs when cerebral 
blood vessels undergo dramatic changes in caliber (45). The 
reduction in blood flow—due to the transient cerebral vasospasm 
that emerges prior to or during pain—is often limited to the pos-
terior area of one hemisphere, leading to cerebral hypoperfusion 
(46). Alternating episodes of hyperperfusion and hypoperfusion 
during migraine may be confined to or start in other brain 
regions or even outside the brain, for example, in the retina and 
choroid. Even though constriction of cerebral and retrobulbar 
arteries is a transitory event, the chronic course with repetitive 
attacks could lead to permanent cerebral and retinal damage (47). 
In fact, retinal ischemia secondary to retinal artery occlusions has 
been described in patients with migraine (35, 48–54). Likewise, 
migraine is a recognized risk factor for ischemic optic neuropathy 
and NTG (55).
Visual symptoms resulting from occipital cortex involvement 
are more common than compromise of retinal or choroidal circu-
lation. Therefore, in patients with these symptoms, OCT changes 
indicate retrograde trans-synaptic neuronal degeneration (RTSD) 
of the retinal ganglion cells (RGCs).
Although ophthalmologists are often the first specialists 
to explore patients with migraine, few studies have addressed 
the involvement of the optic nerve, retina, and choroid in this 
population.
This update reviews the literature on the etiological and 
pathological mechanisms of migraine and the relationship 
between recurrent constriction of cerebral and retrobulbar ves-
sels and ischemic damage to the optic nerve, retina, and choroid 
in affected patients. It also provides evidence in favor of OCT 
for measurement of RNFL thickness and macular and choroidal 
changes in the different variants of migraine, which could be a 
biomarker of RTSD of the RGCs triggered by a lesion located on 
the posterior visual pathway.
Methods
We searched PubMed for articles on the usefulness of OCT 
in patients with CM over a period of 25  years. We identified 
prospective and retrospective studies and case reports based on 
the following key words: migraine, optical coherence tomography, 
OCT, retinal nerve fiber layer, RNFL, retina, choroid, etiology, and 
physiopathology. We selected only articles written in English.
OPTiC neRve STRUCTURAL CHAnGeS 
in MiGRAine
Compromised choroidal blood flow can produce focal ischemic 
damage in the optic disk (55). By using scanning laser polarimetry 
in patients with migraine (both with and without aura), Tan et al. 
(37) reported that migraine had no effect on RNFL.
The latest technological developments have made it possible 
to assess whether the retina is compromised in patients with 
migraine by using OCT to measure RNFL (Table 1). Decreased 
RNFL thickness reflects a reduced number of axons in these 
patients (32). However, results have not been very consistent. 
Thus, whereas some authors observed that mean peripapillary 
RNFL thickness was thinner in migraine patients than in healthy 
controls, others reported only a thinner RNFL in a specific 
TAbLe 1 | Published studies on optical coherence tomography (OCT) in migraine patients.
Reference no of migraine  
patients/HC
OCT type OCT measurements Type of study Results
Martinez  
et al. (32)
70/53 TD-OCT RNFL thickness Case–control Thinner RNFL in the temporal sector in migraine patients.  
Migraine severity is associated with RNFL measurements
Sorkhabi  
et al. (57)
60/30 TD-OCT RNFL thickness Case–control RNFL thinner in nasal quadrant in migraineurs
Kirbas  
et al. (58)
49 CM/40 HC SD-OCT RNFL and FT Case–control Superior quadrant RNFL thickness was thinner in  
CM patients. No macular changes in CM
Gipponi  
et al. (59)
24/16 SD-OCT RNFL thickness Case–control Reduced RNFL thickness in the superior retinal quadrant in  
migraine patients. No influence of illness duration or 
frequency. No changes in macular parameters were found
Ekinci  
et al. (64)
90 (45 MwA, 45 
MwoA)/30
SD-OCT RNFL, GCL, and CT Case–control Reduced RNFL, GCL, and CT in individuals with MwA
Yülek  
et al. (60)
50 (30 MwA, 20 
MwoA)/50
SD-OCT RNFL, GCL, and FT Case–control Average RNFL thickness in migraine patients  
thinner than in HC. No correlation between length of migraine  
history and RNFL thickness
Demircan  
et al. (13)
76 (36 MwA, 40 
MwoA)/38
SD-OCT RNFL and CT Case–control Decreased thickness of RNFL in nasal sectors  
and foveal CT in migraineurs. Macular and choroidal  
thicknesses were not significantly different between  
the MwA and MwoA subgroups
Simsek (62) 40 (with and without 
WML)/40
SD-OCT RNFL, GCL, and CT Case–control Diminished RNFL thickness in migraine patients with WML
Gunes  
et al. (63)
58/58 SD-OCT RNFL Case–control Thinner RNFL thickness on the side of headache and  
on the contralateral side compared with control eyes
Colak  
et al. (16)
45/45 SD-OCT RNFL, GCL, and CT Case–control Reduced RNFL in the superior and inferior quadrants  
of migraineurs compared to HC. Subfoveal, temporal,  
and nasal CT lower in the migraine group than in HC
Feng  
et al. (66)
432/281 SD-OCT RNFL Meta-analysis Decreased RNFL thickness in the migraine patients
Cankaya and 
Tecellioglu (14)
39 (28 MwA, 40 
MwA)/40
SD-OCT RNFL Case–control Reduced FT values in migraine with aura
Reggio  
et al. (61)
72 (12 MwA, 21 
MwoA, 44 CM)/42
SD-OCT RNFL, GCL, FT, CT, and 
TMV
Case–control Thinner RNFL, GCL, and CT in migraineurs, especially  
in CM. RNFL thickness is inversely associated with  
the frequency of migraine attacks
Acer  
et al. (82)
38 MwoA/44 SD-OCT RNFL, GCL, and FT Case–control Sectorial RNFL thinning in MwoA patients.  
No significant changes in the macular area in MwoA
CM, chronic migraine; MwA, migraine with aura; MwoA, migraine without aura; HC, healthy controls; TD-OCT, time domain optical coherence tomography; SD-OCT, spectral 
domain optical coherence tomography; RNFL, retinal nerve fiber layer thickness; GCL, ganglion cell layer thickness; FT, foveal thickness; TMV, total macular volume; CT, choroidal 
thickness; WML, white matter lesions detected using magnetic resonance imaging.
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quadrant (16, 18, 32, 56–62). This selective RNFL involvement 
might be associated with differences in the vulnerability of retinal 
axons to ischemia and with focal perimetric changes (63). The 
suspected axonal damage necessitates monitoring of RNFL thick-
ness and visual field testing in migraine patients (62).
Ekinci et  al. (64) studied subgroups of MwA and MwoA 
patients and demonstrated thinner RNFL in all sectors in MwA, 
but no significant differences in MwoA. The posterior area of a 
single brain hemisphere usually shows cerebral hypoperfusion 
during the attack (32). Thus, RNFL parameters may be more 
altered in MwA than in MwoA (63).
As migraineurs experience headaches almost always on the 
same side, several authors have studied unilateral involvement. 
In their investigation of the association between laterality of 
migraine and RNFL thickness in one-sided headache, Gunes 
et  al. (63) reported a thin RNFL in patients with migraine 
compared with healthy controls and found that even though 
thinning was more relevant on the same side of the headache, 
the asymmetry was not statistically significant. The possibility of 
more relevant thinning of RNFL on the headache side could be 
secondary to lateralized permanent cortical changes, indicating 
that the hemisphere on the side of pain is more altered. Reduced 
blood flow has also been demonstrated in the brain on the 
affected side during attacks (62). Moreover, Hougaard et al. (65) 
explored unilateral headaches and investigated the connection 
between MwA and permanent gray matter anomalies. Using 
magnetic resonance imaging, Simsek (62) observed that in 
migraine patients with white matter lesions (WML), RNFL was 
thinner than in controls and migraine patients with no WML. 
Further research should analyze the relationship between brain 
WML and retinal damage to clarify whether there is a common 
pathogenic mechanism.
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As for the frequency of migraine, some authors (18, 59) did 
not find any correlation with the RNFL thickness, whereas others 
reported an inverse correlation between RNFL thickness and the 
total number of monthly migraine attacks (61).
Peripapillary RNFL thickness measurements could also be 
associated with the length of migraine history. However, whereas 
some authors (18, 59) found no correlation between RNFL thick-
ness and length of migraine history, Feng et  al. (66) reported 
significant changes in RNFL based on the length of the history 
of migraine. Thus, mean RNFL thickness was decreased when 
migraine history was longer than 15 years. While controversial, 
this finding could be associated with glaucoma. In fact, Phelps 
and Corbett (67) observed a higher incidence of low-tension 
glaucoma in migraineurs. The origin of migraine is associ-
ated with the constriction of cerebral and retrobulbar arteries 
(18). During a migraine attack, vasospasm and reduced blood 
perfusion are typically demonstrated in a single hemisphere, 
although other cerebral regions and even retinal layers may also 
be altered by hypoperfusion (50). Migraine episodes may be 
linked to diminished blood flow in the retina and optic nerve, 
leading to irregular ocular perfusion and therefore to ischemia, 
which are implicated in the progression of glaucoma (32). The 
chronic nature of migraine, which is characterized by recurrent 
vasospasms and focal ischemia during attacks, could explain 
structural optic nerve damage, with the subsequent reduction in 
peripapillary RNFL thickness (61).
Furthermore, RNFL thickness values may correlate with the 
severity of headache. An important relationship between mean 
RNFL thickness and the migraine disability assessment score has 
been reported (57, 68). Nevertheless, Yülek et al. (60) evaluated 
the severity of migraine using the visual analog scale (69) and 
observed that the score was not correlated with RNFL thickness. 
The discrepancy might be explained by the use of different scor-
ing systems and the diversity and severity of the headache in the 
study groups (66).
Such discrepant results may be attributed to differences in 
methodology and sample size, ethnic variations, and the absence 
of standardized migraine characteristics, including severity, 
length of migraine history, and frequency of attacks (61). Feng 
et  al. (66) recently performed a meta-analysis of published 
case–control studies to explore changes in RNFL thickness in 
migraine patients assessed using OCT and reported lower peri-
papillary RNFL in patients with migraine than in healthy subjects. 
Therefore, although unspecific, OCT-based measurements of 
RNFL in migraine patients could be a useful technique for the 
study of ocular compromise and for a better understanding of 
pathogenesis.
MACULAR CHAnGeS in MiGRAine
Retrograde trans-synaptic neuronal degeneration of the RGCs 
secondary to damage to structures in the posterior visual pathway 
has been demonstrated in various settings. Segmentation of reti-
nal layers by spectral-domain OCT has enabled a detailed study 
of functional areas. This is most useful at the macula, where the 
density of RGCs is maximal and where other anatomical struc-
tures are absent (70, 71). Several authors have used OCT to study 
possible changes in macular thickness in patients with migraine. 
Their results are contradictory because, although most found no 
change in either foveal or macular parameters in migraine patients 
(18, 59, 62), some reported that foveal thickness (FT) values (19) 
or GCL (61, 64) were thinner in MwA than in MwoA. The more 
diminished blood flow in MwA would explain this finding, given 
that in MwoA, at least between attacks, pulsatile choroidal blood 
flow is not compromised.
Therefore, altered choroidal blood flow can produce ischemic 
damage in retinal tissue, leading to photoreceptor dysfunction 
and eventually GC death (32, 72, 73). In fact, MwA patients seem 
to have a higher risk of ischemic events than MwoA (31, 68).
Finally, no correlation was observed between FT and disease 
duration/length or number of episodes (72).
CHOROiDAL CHAnGeS in MiGRAine
Choroidal vascular deficiency causes decreased choroidal 
thickness (CT), which results in dysfunction of retinal pigment 
epithelium and photoreceptors (74, 75). Choroid thickness may 
decrease as a consequence of decreased blood flow in retinal and 
ciliary vessels (31).
Today, it is possible to estimate CT using advanced OCT 
devices. However, major discrepancies have been observed. Thus, 
whereas some authors report an increase in CT during attacks, 
reflecting altered ocular circulation (76, 77), others report reduced 
CT during attacks (78, 79). Reggio et al. (61) recently reported that 
CT was thinner in migraineurs than in healthy individuals. Colak 
et al. (16) found that RNFL and CT were thinner in MwA than 
in healthy controls, which is secondary to an increasing loss of 
GC and axons. The disparity between authors could be explained 
by the fact that both types of migraine involve changes in blood 
perfusion during their course, albeit with different severity.
Ocular pulse amplitude (OPA) refers to the gap between systolic 
and diastolic IOP. Measured using dynamic contour tonometry, 
it is considered an indirect indicator of choroidal blood flow and 
reflects fluctuations in IOP related to the volume of blood pumped 
in the interior of the eye during the cardiac cycle (80, 81). Acer 
et al. (82) estimated choroidal flow by evaluating OPA and were 
unable to demonstrate relevant dissimilarities in OPA between 
patients with MwoA and controls, thus revealing that pulsatile 
choroidal blood flow is not always altered in these subjects. 
In fact, other studies had previously demonstrated choroidal and 
retinal involvement in patients with migraine (32, 59, 64).
Amaurosis fugax in migraineurs has been proposed as a sign 
of affected choroidal blood flow in patients with migraine (83), 
as have alterations in retinal pigment epithelium on fundoscopy 
after attacks (84).
COnCLUSiOn
The aim of this update was to review the literature on the etiological 
and pathogenic mechanisms of migraine. We analyze evidence on 
the role of OCT for measurement of peripapillary RNFL thickness 
and macular and choroidal changes in migraineurs. We conclude 
that there is abundant evidence on cerebral and retrobulbar 
vascular involvement in the etiology of migraine. The transitory 
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and recurrent constriction of the retinal and ciliary arteries may 
cause ischemic damage to the optic nerve, retina, and choroid 
in migraineurs. Although OCT-based studies show conflicting 
results, our data suggest that the retina and choroid are altered in 
patients with migraine, mainly CM. Moreover, RNFL parameters 
and FT seem to be more altered in MwA than in MwoA. RTSD of 
the RGCs and RNFL following injury to the occipital lobe have 
been reported in experimental studies. Magnetic resonance imag-
ing and OCT could enable us to visualize and quantify RTSD and 
analyze its time course (85). Therefore, OCT-based measurement 
of peripapillary RNFL, GCL, and macular and CT might improve 
our understanding of the pathophysiology of migraine and facili-
tate diagnosis of retino-choroidal compromise and follow-up of 
the effectiveness of therapies in migraine patients. Future studies 
should determine the usefulness of OCT findings as a biomarker 
of migraine. Finally, migraine is such a heterogeneous disorder 
that it will be difficult to cluster patients in categories. Treatment 
(e.g., triptans, ergot derivatives) may also lead to vasoconstric-
tion, which could—theoretically—bring about changes in OCT 
values.
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